Platelet-derived growth factor and alternative splicing: a review.

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Platelet-derived growth factor (PDGF) is a potent mitogen and chemotactic factor implicated in atherosclerosis and neoplasia.
• PDGF exists in three dimeric forms and binds to high-affinity cell-surface and intracellular receptors.
• Both normal and tumor cells secrete PDGF.

Purpose of the Study:

• To review recent literature on the structure, distribution, and biology of PDGF and its receptors.
• To explore the implications of alternative splicing in PDGF A-chain RNA.
• To summarize findings on the functional significance of the exon 6 product (A194-211).

Main Methods:

• Literature review of recent scientific publications.
• Analysis of alternative splicing mechanisms in PDGF A-chain RNA.
• Summary of experimental findings on the functional roles of PDGF A-chain variants.

Main Results:

• Alternative splicing of exon 6 in PDGF A-chain RNA produces two protein variants with distinct carboxy-termini.
• The exon 6 product (A194-211) is found in various cells, including Xenopus embryos, not just transformed cells.
• Evidence suggests A194-211 plays roles in PDGF processing, secretion, mitogenesis, nuclear transport, and heparin binding.

Conclusions:

• Alternative splicing of PDGF A-chain RNA significantly modulates the functional properties of PDGF variants.
• These variations contribute to the complex network of growth factor and cytokine interactions.
• Understanding these mechanisms is crucial for comprehending PDGF's role in disease pathogenesis.